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INTRODUCTION:
DRESS (drug rash, eosinophilia, and systemic symptoms) 
syndrome is a drug hypersensitivity reaction that can present after 
exposure to several drugs mainly antiepileptics and antibiotics. 
2Symptoms includes fever, diffuse rash, eosinophilia and organ 
damage that develops 2-6 weeks after initiation of a medication. 
Common agents are carbamazepine, sulfasalazine, phenobarbital, 
vancomycin, and rarely leflunomide.2 DRESS syndrome can be 
fatal and early withdrawal of medication is crucial for survival. Here 
is a case of a 59-year-old female who was recently prescribed 
leflunomide for rheumatoid arthritis and developed DRESS. 
CASE PRESENTATION:
A 59-year-old female with rheumatoid arthritis on chronic steroids 
and recently prescribed leflunomide presented with diffuse rash, 
stomatitis, eosinophilic dominant leukocytosis and severe diarrhea 
from an OSH. Patient was afebrile and vitals were stable on 
admission. Physical exam revealed diffuse exfoliative dermatitis 
and erythema with involvement of the lips and oral mucosa. Initial 
labs were significant for leukocytosis of 20.7 w/ bandemia and 
eosinophilia 47%, Cr of 7.1, lactate of 2.8 with an anion gap 
metabolic acidosis. The patient was transferred to the ICU for 
airway protection, intubated and eventually underwent 
tracheostomy. During admission, Dermatology, Rheumatology, 
Nephrology, Gastroenterology, Burn and Infectious Disease were 
consulted to see the patient. A skin biopsy eventually confirmed 
the diagnosis of drug reaction with eosinophilia and systemic 
symptoms (DRESS). The patient’s hospitalization however was 
complicated by septic shock due to MSSA pneumonia and VRE 
bacteremia. Despite antibiotics and vasopressors, the patient 
unfortunately expired on the ventilator.
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DISCUSSION: 
To meet the definition of DRESS, patients must have three of the 
four main RegiSCAR criteria including acute rash, fever about 
38C, lymphadenopathy, involvement of at least one internal organ 
and abnormalities in eosinophil counts.1 The most commonly 
affected sites are the liver, kidney and lungs. In this patient, 
pulmonary and renal involvement predominated as evidenced by 
her pneumonia and renal failure. Though rare, there are several 
case reports that report similar instances of DRESS after induction 
of leflunomide.123 Interestingly, there are also case reports that 
suggest this occurrence may be more prevalent in Asian 
populations due to HLA-B phenotypes as was seen in our 
patient.4 Systemic corticosteroids remain the gold standard of 
treatment with supportive care. Unfortunately, some patients can 
fall victim despite maximal medical therapy. Therefore, prompt 
treatment should occur if clinical suspicion is high. 
CONCLUSION: 
Due to its overlap of many clinical symptoms, DRESS can mimic 
other severe systemic disorders.1 It should however, should still  
be kept in the differential diagnosis especially when patients have 
recently been initiated on a medication such as leflunomide. 
Prompt recognition can prevent devastating outcomes as seen 
with this patient.
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